文献速递消化道肿瘤与早癌消化内镜

年轻成人异时性肿瘤风险:与年长成人相比未来进展期腺瘤和大锯齿状息肉的风险

Young adults and metachronous neoplasia: risks for future advanced adenomas and large serrated polyps compared with older adults.
PubMed 文献 · Gastrointest Endosc · 2019-11-21

大锯齿状息肉风险与年龄无关。提示≥50岁患者的监测间隔指南可能适用于年轻成人。

要点

  • <40岁伴指数腺瘤者异时性进展期腺瘤风险显著低于≥60岁者。
  • 40-49岁与50-59岁异时性进展期腺瘤风险相似且均低于≥60岁。
  • 大锯齿状息肉异时性风险与年龄无关。

核心结论

  • 年轻成人(<40岁)伴指数腺瘤的异时性进展期腺瘤风险低于≥60岁者。
  • 40-49岁与50-59岁异时性风险相似,且均低于≥60岁组。
  • 大锯齿状息肉异时性风险与年龄无关。
  • 当前≥50岁患者的监测间隔指南可能适用于年轻成人。

研究设计与样本

  • 队列研究,使用新罕布什尔结肠镜登记处(NHCR)数据。
  • 纳入指数检查至少1个息肉且指数检查后≥1年行随访结肠镜的参与者。
  • 样本量12380名成人。
  • 按指数结肠镜时年龄分层:<40、40-49、50-59、≥60岁(参照组)。
  • 使用logistic回归模型计算调整后风险,协变量包括指数发现、内镜医师腺瘤检出率、性别、吸烟、BMI、随访时间(月)、肠道准备质量及结直肠癌家族史。

主要发现

  • 异时性进展期腺瘤绝对风险在年轻患者中低于≥60岁患者。
  • 大(≥1 cm)异时性锯齿状息肉风险与年龄无关。

关键数值与推荐

  • 异时性进展期腺瘤定义:腺瘤≥1 cm、伴绒毛成分或高级别异型增生,或结直肠癌。
  • 大锯齿状息肉定义:≥1 cm。

临床怎么用

  • 对<40岁伴指数腺瘤患者,异时性进展期腺瘤风险低,可考虑沿用≥50岁患者的监测间隔指南。
  • 40-49岁患者异时性风险与50-59岁相似,监测策略可参考50-59岁组。
  • 大锯齿状息肉风险与年龄无关,监测时仍需关注锯齿状病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Recent increases in colorectal cancer (CRC) incidence in adults younger than 50 years of age have led to more colonoscopies in this age group. As a result, there may be an increasing number of adults <50 years old with polyps detected. There is concern that younger adults may require closer follow-up. Our goal was to use data from the New Hampshire Colonoscopy Registry (NHCR) to examine the risk for metachronous advanced adenomas (AAs) and large (>1 cm) serrated polyps in younger versus older adults who return for a follow-up colonoscopy. METHODS: Our cohort consisted of NHCR participants with at least 1 polyp on index examination and a follow-up colonoscopy at least 1 year after the index examination. Outcomes were the risks for metachronous AAs (adenomas ≥1 cm, with villous elements or high-grade dysplasia, or CRC) and large (≥1 cm) serrated polyps. We present absolute risk and adjusted risks from a logistic regression model stratified by age at index colonoscopy (<40, 40-49, 50-59, and 60+ [reference]). Covariates included index findings, endoscopist adenoma detection rates, sex, smoking, body mass index, follow-up time (months), bowel preparation quality, and family history of CRC. RESULTS: In our sample of 12,380 adults, absolute risk for metachronous AA was lower for younger patients than for patients aged ≥60. After adjusting for covariates, when comparing with the 60+ group (reference), the lowest risk was observed in those younger than 40 years (odds ratio, .19; 95% confidence interval, .05-.80). Of note, similar risks were observed in the 40 to 49 age group (odds ratio, .61; 95% confidence interval, .41-.92) and 50 to 59 age group (odds ratio, .71; 95% confidence interval, .58-.86). The risk for large metachronous serrated polyps was not associated with age. CONCLUSIONS: Younger adults aged <40 with index adenomas had a lower risk for metachronous AAs than those aged ≥60. The 40- to 49-year age group was found to have metachronous risk similar to the 50- to 59-year age group, with both less than the ≥60 age group. These data suggest that current surveillance interval guidelines for patients aged ≥50 years may appropriately be used with younger adults.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Anderson JC, Robinson CM, Butterly LF, et al. Young adults and metachronous neoplasia: risks for future advanced adenomas and large serrated polyps compared with older adults. Gastrointest Endosc. 2019. PMID: 31759925. doi:10.1016/j.gie.2019.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。